GRECAP

Cardiovascular Research Group

The lines of work of our group focus on Heart Failure, psychosocial determinants and cardiovascular risk and specific cardiovascular risk factors: hypertension and atrial fibrillation. The group is composed of five doctors (five family doctors and one statistician), a specialist in preventive medicine, two non-doctor family doctors and two case management nurses. Some of the members have been trained in Institutes of Excellence such as the IMIM, Germans Trias i Pujol or l'IRVH. In the 2014-2017 period, group members have been principal investigators of six competitive research projects. In the last three years the group has published more than 90 articles in journals indexed with impact factor. The group collaborates with international institutes and universities.

Group projects

PI: Verdú Rotellar, José María. Efecto de la reducción en la ingesta dietética de sal en la morbimortalidad de los pacientes con insuficiencia cardíaca: ensayo clinico SALOMEH (SALt On Morbimortality Events in Heart failure). Funding: Instituto de Salud Carlos III. Duration: 2019 - 2021.

The group participates in the following projects

PI: Buenaventura Bolibar. Plataforma IMPACT - Programa 1 Medicina Predictiva.

Funding: Consorcio Centro de Investigación Biomédica en RED (CIBER). Duration: 2021-2023

PI: Violán Fors, Concepció. Construcción y validación de un Score predictivo de riesgo de institucionalización, ingresos hospitalarios y mortalidad, en mayores de 65 años con multimorbilidad y fragilidad. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022

PI: - -, IP no primaria. Monitoring of SARS-CoV-2 seroprevalence among primary health care patients as a sentinel COVID-19 surveillance in Barcelona health region. Funding: Departament de Salut. Duration: 2020 - 2022

PI: Rosalia Santes Mases. Adaptación cultural de la escala "Heart Failure-Specific Health literacy scale" y determinación de las propiedades psicométricas. Funding: Fundació Infermeria i SocietatDuration: 2020 - 2021

Group Publications

Abellana R, Gonzalez-Loyola F, Verdu-Rotellar JM, Bustamante A, Palà E, Clua-Espuny JL, Montaner J, Pedrote A, Del Val-Garcia JL, Ribas Segui D, Muñoz MA. Predictive model for atrial fibrillation in hypertensive diabetic patients. Eur J Clin Invest. 2021 Jun; doi:10.1111/eci.13633. Epub 2021 Jun 19. PMID:34148231. IF: 4,686.

The group participates in the following publications

Calero-Molina E, Hidalgo E, Rosenfeld L, Verdú-Rotellar JM, Verdú-Soriano J, Garay A, Alcoberro L, Jimenez-Marrero S, Garcimartin P, Yun S, Guerrero C, Moliner P, Delso C, Alcober L, Enjuanes C, Comin-Colet J. The relationship between self-care, long-term mortality, and heart failure hospitalization: insights from a real-world cohort study. Eur J Cardiovasc Nurs. 2021 May; doi:10.1093/eurjcn/zvab011. Epub 2021 May 19. PMID:34008849. IF: 3,908.

Carralero-Martínez A, Muñoz Pérez MA, Pané-Alemany R, Blanco-Ratto L, Kauffmann S, Ramírez-García I. Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: study protocol for a randomized controlled trial. Trials. 2021 May; 22(1):356. doi:10.1186/s13063-021-05321-6. Epub 2021 May 20. pmc:PMC8136758. PMID:34016168. IF: 1,975.

Fernández-Liz E, Vivó-Tristante P, Aranzana-Martínez A, Barceló-Colomer ME, Larrosa-Garcia M, Del Val García JL, Martín-Gracia E; ; on behalf of the Urinary Incontinence Improvement Clinical Group. Long-term effectiveness of an intervention to enhance mirabegron use revision and its deprescribing: 36-month follow-up of a quasi-experimental trial in primary care. Curr Med Res Opin. 2021 Apr; 37(4):703-710. doi:10.1080/03007995.2021.1885366. Epub 2021 Feb 26. PMID:33538192. IF: 2,580.

López M, Gallego C, Abós-Herrándiz R, Tobella A, Turmo N, Monclús A, Martinez A, Rami A, Navas E, Muñoz MA. Impact of isolating COVID-19 patients in a supervised community facility on transmission reduction among household members. J Public Health (Oxf). 2021 Sep; 43(3):499-507. doi:10.1093/pubmed/fdab002. pmc:PMC7928768. PMID:33554257. IF: 2,341.

Olona Tabueña N, Rodríguez Fuertes G, Del Val García JL, Sánchez Callejas A, Feijóo Rodríguez V, Rodríguez Pérez E, Larrea Alfonso PJ. [Characteristics and factors associated with the severity of COVID-19 in Primary Care professionals followed in a Basic Prevention Unit.]. Rev Esp Salud Publica. 2021 Oct; 95. Epub 2021 Oct 22. Spanish. PMID:34675174. IF: 0,756.

Laguna JC, Alegret M, Cofán M, Sánchez-Tainta A, Díaz-López A, Martínez-González MA, Sorlí JV, Salas-Salvadó J, Fitó M, Alonso-Gómez ÁM, Serra-Majem L, Lapetra J, Fiol M, Gómez-Gracia E, Pintó X, Muñoz MA, Castañer O, Ramírez-Sabio JB, Portu JJ, Estruch R, Ros E. Simple sugar intake and cancer incidence, cancer mortality and all-cause mortality: A cohort study from the PREDIMED trial. Clin Nutr. 2021 Oct;40(10):5269-5277. IF:7,64

Díaz-López A, Becerra-Tomás N, Ruiz V, Toledo E, Babio N, Corella D, Fitó M, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez JA, Serra-Majem L, Estruch R, Tinahones FJ, Lapetra J, Pintó X, Tur JA, López-Miranda J, Cano Ibañez N, Delgado-Rodríguez M, Matía-Martín P, Daimiel L, de Paz JA, Vidal J, Vázquez C, Ruiz-Canela M, Bulló M, Sorlí JV, Goday A, Fiol M, García-de-la-Hera M, Tojal Sierra L, Pérez-Farinós N, Zulet MÁ, Sánchez-Villegas A, Sacanella E, Fernández-García JC, Santos-Lozano JM, Gimenez-Gracia M, Del Mar Bibiloni M, Diez-Espino J, Ortega-Azorin C, Castañer O, Morey M, Torres-Collado L, Sorto Sanchez C, Muñoz MÁ, Ros E, Martinez-Gonzalez MA, Salas-Salvadó J; PREDIMED-Plus Investigators. Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial. Am J Nephrol. 2021;52(1):45-58. IF: 3,754.

Paz-Graniel I, Babio N, Becerra-Tomás N, Toledo E, Camacho-Barcia L, Corella D, Castañer-Niño O, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez JA, Serra-Majem L, Estruch R, Tinahones FJ, Fernandez-Aranda F, Lapetra J, Pintó X, Tur JA, García-Rios A, Bueno-Cavanillas A, Gaforio JJ, Matía-Martín P, Daimiel L, Sánchez VM, Vidal J, Prieto-Sanchez L, Ros E, Razquin C, Mestres C, Sorli JV, Cuenca-Royo AM, Rios A, Torres-Collado L, Vaquero-Luna J, Pérez-Farinós N, Zulet MA, Sanchez-Villegas A, Casas R, Bernal-Lopez MR, Santos-Lozano JM, Corbella X, Mateos D, Buil-Cosiales P, Jiménez-Murcia S, Fernandez-Carrion R, Forcano-Gamazo L, López M, Sempere-Pascual MÁ, Moreno-Rodriguez A, Gea A, de la Torre-Fornell R, Salas-Salvadó J; PREDIMED-Plus Investigators. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population. Eur J Nutr. 2021 Aug;60(5):2381-2396. IF:5,311

Domingo M, Lupón J, Girerd N, Conangla L, de Antonio M, Moliner P, Santiago-Vacas E, Codina P, Cediel G, Spitaleri G, González B, Diaz V, Rivas C, Velayos P, Núñez J, Bayes-Genís A. Lung ultrasound in outpatients with heart failure: the wet-to-dry HF study. ESC Heart Fail. 2021 Dec;8(6):4506-4516.  IF: 3,20

Codina P, Lupón J, Borrellas A, Spitaleri G, Cediel G, Domingo M, Simpson J, Levy WC, Santiago-Vacas E, Zamora E, Buchaca D, Subirana I, Santesmases J, Diez-Quevedo C, Troya MI, Boldo M, Altmir S, Alonso N, González B, Rivas C, Nuñez J, McMurray J, Bayes-Genis A. Head-to-head comparison of contemporary heart failure risk scores. Eur J Heart Fail. 2021 Dec;23(12):2035-2044. IF :18,174

de la Sierra A, Mateu A, Gorostidi M, Vinyoles E, Segura J, Ruilope LM. Antihypertensive therapy and short-term blood pressure variability. J Hypertens. 2021 Feb 1;39(2):349-355. IF : 4.77

Gijón-Conde T, Rubio E, Gorostidi M, Vinyoles E, Armario P, Rodilla E, Segura J, Divisón-Garrote JA, García-Donaire JA, Molinero A, Ruilope LM. 2021 Spanish Society of Hypertension position statement about telemedicine. Hipertens Riesgo Vasc. 2021 Oct-Dec;38(4):186-196. IF : 0.59

Indicators

Indicator

2021

Researchers with PhD

5

Total number of projects in which group members have participated

4

Total number of projects in which the PI of the project has belonged to the group

1

Total Funding

194.530 €

Scientific publications in indexed journals

13

Total Impact factor

54,99

Nº of articles in Q1 journals

5

Q1 IF

39,56

Nº of articles in Q2 journals

2

Q2 IF

6,991

Anar a l'inici